Albertsons Companies appointed Meg Whitman as Executive Chair of its Board of Directors effective September 8, 2026, expanding the board from 10 to 11 members. Kim Fennebresque transitioned from Chair to Lead Independent Director. Whitman will serve as an operations and strategic advisor to CEO Susan Morris, leveraging her technology expertise to support AI integration and operational streamlining. She receives a $100,000 annual base salary and restricted stock units valued at $8.9 million vesting in one year. As an employee of the company, Whitman is classified as non-independent under NYSE rules. Albertsons operates as a leading food and drug retailer in the United States.

Albertsons Companies reported first quarter fiscal 2026 results with net income of $84.7 million ($0.17 per share) and adjusted net income of $210.3 million ($0.42 per share). The company is lowering its fiscal 2026 outlook, reducing expected adjusted net income per share to $1.75-$1.85 from $2.22-$2.32 and adjusted EBITDA to $3.550-$3.625 billion from $3.850-$3.925 billion. To address performance softness, the company launched ACI Edge, a realignment consolidating 11 divisions into four regions and centralizing center-store merchandising. The company also announced a quarterly cash dividend of $0.17 per share payable August 7, 2026. Albertsons is a food and drug retailer operating stores across 35 states.

Albertsons Companies, Inc. announced on July 23, 2026, that Sharon McCollam, President and Chief Financial Officer, plans to retire later this year. McCollam will remain in her role until a successor is named and will subsequently serve in an advisory capacity through the end of the fiscal year on February 27, 2027. Albertsons Companies, Inc. is a food and drug retailer in the United States.